ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302035 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302035; 2) Community: the network communities that were significantly associated with the response to NSC 302035; 3) Molecule: the relationships between components within communities and NSC 302035; 4) MDR: the compounds that were significantly associated with the NSC 302035.

NSC Compound Enrichment Correlation
NSC 672210 Null 0.0236268253072453 0.31798625
NSC 684409 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone 0.0236268253072453 0.23539824
NSC 685285 Null 0.0236268253072453 0.086925001
NSC 686551 Null 0.0236268253072453 0.29899712
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0236268253072453 0.60288886
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.0236268253072453 -0.13023486
NSC 749600 Null 0.0236268253072453 0.35164751
NSC 750050 Null 0.0236268253072453 0.38887123
NSC 758670 TANNIC ACID 0.0236268253072453 -0.20902723
NSC 46213 Null 0.0246753314031135 -0.12282455
Total:95  Current:57    [First] [Prev] [Next] [Last]